7800 Susquehanna St.
Pittsburgh, PA 15208
Full Time Employees: 4
|Dr. Jonathan Kaufman M.B.A., Ph.D.||Co-Founder, Chairman, CEO, Pres, Sec. & Treasurer||183.3k||N/A||1966|
|Dr. Michael B. Chancellor M.D.||Co-Founder, Chief Medical Officer & Director||101.27k||N/A||1959|
|Mr. Douglas Johnston CPA||Chief Financial Officer||48k||N/A||1985|
|Ms. Michele Gruber||Director of Operations||N/A||N/A||N/A|
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. The company was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.
Lipella Pharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.